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Background. Medical gender-affirming interventions (GAI) are important in the transition process of many trans persons.The aim
of this study was to examine the associations between GAI and quality of life (QoL) of transitioned trans individuals.Methods. 143
trans persons were recruited from a multicenter outpatient Swiss population as well as a web-based survey. The QoL was assessed
using the Short Form (36) Health Survey questionnaire (SF-36). Depressive symptoms were examined using the Short Form of
the Center for Epidemiologic Studies-Depression Scale (ADS-K). Multiple interferential analyses and a regression analysis were
performed. Results. Both transfeminine and transmasculine individuals reported a lower QoL compared to the general population.
Within the trans group, nonbinary individuals showed the lowest QoL scores and significantly more depressive symptoms. A
detailed analysis identified sociodemographic and transition-specific influencing factors. Conclusions. Medical GAI are associated
with better mental wellbeing but even after successful medical transition, trans people remain a population at risk for low QoL and
mental health, and the nonbinary group shows the greatest vulnerability.
1. Introduction
Gender incongruence (GI) is a condition in which the gender
identity or gender expression of a person is discordant with
their assigned sex characteristics. GI is often accompanied by
clinically relevant psychological distress, then called gender
dysphoria (GD) [1]. Individuals with a GI are usually referred
to as trans persons.This umbrella term covers persons whose
gender identity is the opposite of their assigned sex (trans-
men and transwomen). It also includes persons who place
themselves between or outside the binary gender categories
(nonbinary persons).
GD can present with a strong rejection of the anatomical
characteristics—primarily the sexual features [1]. Further-
more, because of the ubiquitous social stigma that trans per-
sons experience [2], GD can lead to negative self-image and
mental health problems [3–5]. In particular, many trans indi-
viduals experience depressive episodes during their lifetime,
which in the worst case are associated with suicidal behavior
[3]. To overcome this feeling of GD, many trans persons seek
medical help and undergo gender-affirming interventions
(GAI) (e.g., sex hormonal treatment or gender-affirming
surgery). Nowadays, it is generally accepted that both hor-
monal and surgical interventions can alleviate GD [6–8].
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Previous evidence on the negative psychological andQoL
effects of GAI is rare and is based on older studies [9, 10]. In
contrast, the positive effects on psychological wellbeing and
QoL in trans persons have been reported more frequently
[7, 8, 11–17]. Several studies have shown that a medical
transition can positively impact the social status of treated
trans persons [18]. However, it is also known that various
psychosocial factors such as old age [7], unemployment [7,
19], being single [7, 20], having a low level of education [7],
and depressive disorders [12] can negatively influence QoL.
Many GAI require long-term care and follow-up, which can
have a negative impact on wellbeing [21]. Consequently, the
QoL of transitioned trans persons remains low compared to
the general population [16, 22].
The literature is unclear regarding potential gender differ-
ences within the trans population.While some authors found
no considerable differences in QoL scores between trans-
women and transmen [12, 23], others noted significant diver-
gences. For example, Parola et al. reported that transwomen
have a better QoL in different mental and physical domains
than transmen [14]. In contrast, Motmans et al. [7] found
lower QoL scores in transwomen compared to transmen.
Similar conflicting evidence is found in studies on mental
health comparisons between trans persons. While some
studies demonstrated worse mental health in transwomen
[24], others found no gender-related differences [25].
Furthermore, this previous outcome research mainly
used binary assumptions about gender identities and focused
on either transfeminine or transmasculine individuals.There
is little research on gender nonbinary persons [26].This situa-
tion is caused bymany factors but is particularly related to the
theoretical andmethodological issues of earlier study designs
[27]. However, this unique subpopulation of trans persons
seems to be especially prone to stigmatization [2], poor self-
rated health [28], and high rates of affective disorders [29].
Therefore, the aim of this present study was to examine
the associations between GAI and QoL in transitioned trans
individuals. In particular, we investigated potential psycho-
logical and social factors that could influence the wellbeing
of trans persons. We emphasized a broader gender spectrum
by including gender nonbinary persons. For the first time,
this provides a simultaneous comparison between different
transitioned trans subgroups in terms of QoL.
2. Methods
We performed a retrospective cross-sectional multicenter
study on persons self-identified as being trans.The study was
performed in collaboration with the Department of Plastic,
Reconstructive, Aesthetic, andHand Surgery at Basel Univer-
sity Hospital, the Department of Psychiatry and Psychother-
apy of the University Hospital Zurich, the Department of
Psychiatry and Psychotherapy of the University Hospital
Bern, and the Psychiatric Services Hospitals of the Canton of
Solothurn.
2.1. Sample. We applied two ways of recruitment. Trans
persons who had formerly presented to the outpatient
clinic of the collaborating hospitals were invited by post
to participate in the study and could choose between a
paper-based form and a web-based survey. To maximize
the number of participants, recruiting was expanded to the
larger Swiss trans community via advocacy groups. These
participants could only use the web-based survey. Data was
collected anonymously in both ways of recruitment. The
inclusion criteria included aminimum age of 18 years, a good
command of the German language, and self-identification of
being transitioned, that is, participants defining their medical
transition to be completed independent of the extent of
medical affirming interventions performed. Here, we defined
the latter by the absence of psychiatric treatment associated
with gender dysphoria, a minimum of one year of hormonal
treatment, and no planned surgical intervention for the
upcoming year. The exclusion criterion was an unfinished
medical transitioning process.The study was approved by the
Ethics Committee of Basel.
2.2. Measurements
2.2.1. Quality of Life. The Short Form (36) Health Survey
questionnaire (SF-36) is a widely used self-reported question-
naire on QoL and health status which assesses four mental
domains of health (vitality, social functioning, emotional
role functioning, and mental wellbeing) and four physical
domains of health (physical functioning, physical role func-
tioning, bodily pain, and general health). The two global
measures can be derived from all physical and all mental
domains, respectively, and are referred to as the physical
component summary (PCS) and themental component sum-
mary (MCS). Answers were transformed via a standardized
measure according to the predefined scoring algorithm to
yield a total score ranging from zero to 100; higher values
indicate a higher subjective quality of life. Cronbach’s alpha is
an indicator of internal consistency and yielded a high score
of .87.
In addition to group comparisons, we performed a 𝑡-
test group comparison of the mean scores of transfeminine
and transmasculine individuals with mean scores of men
and women in the German general population. The SF-36
German general population data were taken from the 1995
German population survey [30]. No standard values exist for
nonbinary individuals.
2.2.2. Depressive Symptoms. The Allgemeine Depression-
sskala (ADS-K) is a validated German short form adaptation
of the Center for Epidemiologic Studies Depressions Scale
(CES-D), a screening instrument for depressive symptoms
[31, 32]. It covers 15 items on affective, motivational, psy-
chosocial, somatic, and cognitive symptoms. The total score
ranges from zero to 45, with higher values indicating more
severe depressive symptoms. A score ≥ 18 is the cut-off for
clinically relevant depressive disorders [33]. For reliability
analysis, Cronbach’s alpha was calculated to assess the inter-
nal consistency of the ADS-K questionnaire in our sample.
With a Cronbach’s alpha value of .85, the internal consistency
of the questionnaire is high and comparable with the reported
value of 𝛼 = .88–.95 in the ADS-K manual [31].
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Table 1: Sociodemographic characteristics. aOne-way ANOVA. bChi-square test.
Transfeminine Transmasculine Nonbinary 𝑝
Age (M (SD)) 51.51 (17.06) 35.95 (12.79) 42.16 (24.41) <0.01a
Level of education (𝑛 (%))
Primary school 3 (3.9%) 0 0
0.06b
Secondary school 3 (3.9%) 4 (10%) 2 (8%)
Apprenticeship 28 (36.8%) 15 (37.5%) 3 (12%)
A-levels 9 (11.8%) 7 (17.5%) 8 (32%)
University/technical college 33 (43.4%) 12 (30%) 11 (44%)
Other 0 2 (5%) 1 (4%)
Relationship status (𝑛 (%))
Single 41 (53.9%) 17 (42.5%) 11 (44%)
<0.01bIn a relationship 33 (43.4%) 23 (57.5%) 7 (28%)
Other 2 (2.6%) 0 7 (28%)
Work situation (𝑛 (%))
Self-employed 15 (19.7%) 5 (12.2%) 4 (16.7%)
0.07bEmployed 27 (35.5%) 25 (61%) 6 (25%)
Unemployed 15 (19.7%) 3 (7.3%) 5 (20.8%)
Other 19 (25%) 8 (19.5%) 9 (37.5%)
Housing situation (𝑛 (%))
With family 13 (17.1%) 9 (22%) 3 (12%)
0.1b
With friends/shared flat 7 (9.2%) 3 (7.3%) 7 (28%)
With partner 22 (28.9%) 13 (31.7%) 2 (8%)
Alone 31 (40.8) 15 (36.6%) 13 (52%)
Other 3 (3.9%) 1 (2.4%) 0
2.2.3. Sociodemographic Characteristics. The sociodemo-
graphic survey was thematically divided into three categories:
general, trans-specific, and transition-specific. In the general
part, participants self-reported their age, current housing
situation, relationship status, level of education, and current
work situation. The trans-specific variables included gender
assigned at birth and preferred gender label. The transition-
specific variables included prior hormonal and surgical
affirming interventions.
2.3. Data Analysis. We used SPSS version 22.0 for all statis-
tical analysis. Frequency distributions were analyzed using
chi-square tests. A set of 𝑡-tests and one-way ANOVA tests
were calculated to compare the mean scores between gender
groups. We performed multiple multivariate regression anal-
yses to identify predictor variables to QoL. We considered
two-tailed 𝑝 values < 0.05 to be significant.
3. Results
3.1. Sample. We contacted 373 individuals from outpatient
clinics via a written form and asked them to participate in the
study; 66 completed questionnaires were returned (response
rate of 18.0%). There were 201 web participants, of whom
77 individuals completed it. There was an inclusion rate of
38%. In total, 143 individuals completed the questionnaire
and were included. In this study, we defined a transfeminine
person as an individual self-identified as female with a
male sex assigned at birth and a transmasculine person
as an individual self-identified as male with a female sex
assigned at birth; a gender nonbinary person is an individual
self-identified in-between male and female gender or self-
identified as no gender, independent of the assigned sex at
birth. The majority of our sample was transfeminine (𝑛 =
77; 53.8%) followed by transmasculine (𝑛 = 41; 28.7%)
and nonbinary gender (𝑛 = 25; 17.5%). Within the group
of nonbinary individuals, 7 persons (28%) had a male sex
assigned at birth and 17 persons (68%) had a female sex
assigned at birth. One person stated to have an “other” sex
assigned at birth.
3.2. Sociodemographic Characteristics. Participants’ age
ranged from 18 to 75 years (Table 1). Transfeminine
individuals were older than transmasculine individuals and
nonbinary individuals; the difference between transfeminine
and transmasculine individuals was significant (𝑝 < 0.01).
There was no significant difference in the level of education,
relationship status, work, and housing situation between
groups. Post hoc test of the variable relationship status
provided no significant differences between groups (data not
shown).
3.3. Transition-Specific Characteristics. Compared to trans-
masculine individuals, transfeminine individuals were sig-
nificantly (𝑝 < 0.01) older at coming out and proceeded
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Table 2: Transition-specific data. aOne-way ANOVA.
Transfeminine (𝑛 = 77) Transmasculine (𝑛 = 41) Nonbinary (𝑛 = 25) 𝑝
Age at coming out (M (SD)) 34.8 (14.66) 22.73 (22.32) 28.04 (10.88) <0.01a
First steps in transition (M (SD)) 35.12 (14.23) 27.12 (10.31) 27.62 (10.91) <0.01a
Current hormone therapy (𝑛) 63 41 12
Hormone therapy in years (𝑛)
0–5 22 17 6
6–10 4 4 1
11–20 8 1 1
>20 6 2 0
Overall gender-affirming surgery (𝑛) 65 39 10
Mammoplasty (𝑛) 45 38 10
Genital reconstruction (𝑛) 50 12 1
Table 3: Mean scores (M (SD)) of SF-36 domains and global measures and group comparison by one-way ANOVA.
Transfeminine Transmasculine Nonbinary 𝑝
Physical
Physical functioning 88.16 (21.52) 94.27 (9.46) 91.25 (9.47) 0.1
Physical role 81.91 (32.81) 92.31 (20.0) 76.0 (37.14) 0.04
Bodily pain 80.57 (27.06) 82.66 (23.06) 74.16 (27.8) 0.45
General health 74.13 (22.73) 72.58 (20.09) 53.36 (26.75) <0.01
Mental
Vitality 56.76 (24.47) 59.87 (17.88) 40.2 (20.23) <0.01
Social functioning 77.17 (27.3) 79.69 (28.0) 65.0 (31.66) 0.16
Mental health 72.72 (22.78) 72.11 (19.93) 52.5 (21.44) <0.01
Emotional role 75.32 (37.62) 89.47 (25.83) 46.67 (45.13) <0.01
Component summary
Physical (PCS) 53.05 (8.44) 53.76 (5.88) 53.75 (7.9) 0.87
Mental (MCS) 46.37 (12.48) 49.8 (10.25) 35.18 (14.13) <0.01
faster into the transition process (transmasculine individ-
uals after 4.39 years versus transfeminine individuals after
0.32 years) (Table 2). On one hand, nonbinary individuals
showed distinctly different traits representing a population
“in-between” transfeminine and transmasculine individuals
concerning distribution of age at coming out and first steps
into transition.On the other hand, bymaking the first steps of
medical transition before actually coming out, the nonbinary
group significantly differed from the binary trans people.The
same dichotomous pattern between binary and nonbinary
trans persons was also found in current hormone treatment
and the overall demand for gender-affirming surgical inter-
ventions. Within the binary group, an analysis of the surgical
interventions performed showed gender-specific patterns.
While mastectomy was very common (92.6%) and phallo-
plasty was less used (29.2%) in men, breast augmentation
(58.4%) and vaginoplasty (64.9%) were reported in a more
similar frequency in women.
3.4. ADS-K. Gender had a significant effect on ADS-K scores
between groups (𝐹 = 5.98; 𝑝 ≤ 0.01). Post hoc tests demon-
strate that gender nonbinary individuals rated significantly
higher (M (SD): 18.04 (10.17)) compared to transfeminine
(M (SD): 10.76 (7.80)) and transmasculine (M (SD): 12.59
(10.16)) individuals. This suggests higher affective distress in
this population. The difference between transfeminine and
transmasculine individuals was statistically nonsignificant.
3.5. SF-36. Transfeminine individuals scored worse than
transmasculine individuals did in both the somatic and
mental domains (Table 3), except in the domains general
health and mental health. However, these differences were
not significant. Nonbinary individuals performed worse than
the other two groups in seven out of eight domains with
significant results in the domains physical role, general
health, vitality, mental health, and emotional role. In addi-
tion, the mental component summary (MCS) score of the
nonbinary persons was significantly lower than that in the
other groups.
In comparison to the German general population, both
transfeminine and transmasculine individuals scored lower
in the mental component summary score (MCS) of the SF-36
(Table 4). In transfeminine individuals, the mental domains
social functioning, emotional role, and the MCS showed
significantly reduced values compared to the general female
population. Transmasculine individuals rated the mental
domains vitality and social functioning significantly lower
than the general male population.
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Table 4: 𝑡-test comparison of mean scores (M (SD)) of SF-36 domains between groups and the general German population.
Transfeminine Cis women 𝑝 Transmasculine Cis men 𝑝
Physical
Physical functioning 88.16 (21.52) 82.71 (23.17) 0.03 94.27 (9.46) 89 (20.15) <0.01
Physical role 81.91 (32.81) 80.41 (33.02) 0.69 92.31 (20.0) 87.3 (29.62) 0.13
Bodily pain 80.57 (27.06) 75.99 (27.68) 0.14 82.66 (23.06) 82.47 (26.56) 0.96
General health 74.13 (22.73) 66.64 (19.67) 0.01 72.58 (20.09) 69.59 (20.63) 0.35
Mental
Vitality 56.76 (24.47) 60.62 (18.47) 0.18 59.87 (17.88) 66.17 (18.01) 0.04
Social functioning 77.17 (27.3) 87.02 (18.92) <0.01 79.69 (28.0) 90.67 (17.51) 0.02
Mental health 72.72 (22.78) 71.44 (16.29) 0.65 72.11 (19.93) 76.55 (16.06) 0.18
Emotional role 75.32 (37.62) 88.77 (26.34) <0.01 89.47 (25.83) 92.06 (24.58) 0.54
Component summary
Physical (PCS) 53.05 (8.44) 49.09 (10.6) <0.01 53.76 (5.88) 51.42 (9.62) 0.03
Mental (MCS) 46.37 (12.48) 50.71 (8.39) 0.01 49.8 (10.25) 52.44 (7.7) 0.15
The physical component summary scores were signifi-
cantly higher in both trans groups compared to the general
population. Within all the physical domains, QoL was rated
higher compared to the general population in both transfem-
inine and transmasculine individuals. Among these, scores
in the domain physical functioning were significant in both
transfeminine and transmasculine individuals compared to
the general population. Transfeminine individuals also rated
general health significantly higher than the general popula-
tion.
3.6. Interferential Analysis. Factors that have a significant
negative influence on quality of life in the global measures
include young age, having an “other” relationship status
(different from being in a relationship and being single),
being unemployed, and having an “other” work situation
(different from being employed or unemployed) (Table 5).
Medical transition measures such as hormone therapy
and gender-confirmation surgery have strong implications on
the mental wellbeing and self-rated quality of life depicted by
significantly reduced MCS values (Table 6).
3.7. Multiple Regression Analysis. A block-wise multiple
regression analysis was performed to estimate the relation-
ships between MCS and gender, medical affirming inter-
ventions, work situation, and relationship status (Table 7).
The full model explained 20% of the variance (𝑅2 =
.196, 𝐹(8/113 = 4.68), and 𝑝 < 0.001) with only gender and
employment having significant regression weights. Gender
contributed more to the model than employment.
4. Discussion
This study expanded research into the associations between
gender-affirming interventions (GAI) and quality of life
(QoL) of transitioned trans persons. Compared to the general
population, these findings indicate poor quality of life in trans
persons who had performed those medical interventions
that they deemed necessary for their transition. However,
not all trans persons are affected to the same extent by
this situation: among trans people, the nonbinary group
scored significantly worse on QoL and depressive symptoms
than the transfeminine and transmasculine participants. First
interferential analysis identified different sociodemographic
and transition-specific influencing factors on theQoLof tran-
sitioned trans persons. Multiple regression analysis, however,
failed to validate a relevant correlation betweenGAI andQoL.
The model only confirmed a significant correlation between
gender, work situation, and QoL.
4.1. Comparison to the General Population. To the best of our
knowledge, this is the first study to evaluate QoL in both
transfeminine and transmasculine individuals compared to
the general population. In agreement with previous findings
in transwomen [13] and transmen [7, 16, 20], the participants
showed worse scores than the general population in virtually
all measurement ranges of mental QoL. Of particular note
is the significant difference in the social functioning domain
of the SF-36, which was found in both genders. A possible
explanation for this difference might be the still prevalent
gender-binary model of western societies which reinforces
the social stigma of trans persons [34]. These experiences of
stigmatization constitute a specific so-called minority stress,
which in turn affects the social functioning, the physical and
mental health, and ultimately the QoL of trans persons [35].
A different picture is provided with regard to the physical
dimensions of the QoL. We found a significantly increased
physical component summary (PCS) score in both trans-
feminine and transmasculine participants compared to the
general population. In addition, both groups showed a
significant difference in the “physical functioning” domain.
This concurs with observations that found physical-related
QoL to be higher in transwomen [11, 13]. Ainsworth and
Spiegel [11] suggested higher rates of chronic and acute
disease in the general population as an underlying cause for
this discrepancy. Following this argument, another possible
explanation for this finding might be a selection bias of
physically healthier individuals in our sample as most of
6 BioMed Research International
Table 5:Descriptive results of SF-36 globalmeasures and sociodemographic datawith group comparison ofmean scores (M (SD)) by one-way
ANOVA.
PCS 𝐹 (df) 𝑝 MCS 𝐹 (df) 𝑝
Age
18–35 years (𝑛 = 40) 53.22 (7.41)
2.29 (2) 0.11
41.17 (13.99)
3.02 (2) 0.0536–50 years (𝑛 = 32) 55.76 (4.74) 46.61 (13.4)
>50 years (𝑛 = 45) 52.04 (9.17) 46.61 (13.4)
Level of education
Primary school 46.94 (15.16)
1.66 (5) 0.15
43.13 (12.83)
1.14 (5) 0.34
Secondary school 50.68 (7.27) 45.90 (10.35)
Apprenticeship 51.59 (8.98) 45.29 (13.42)
A-levels 54.39 (5.86) 40.04 (14.75)
University/technical college 55.14 (6.6) 47.05 (12.59)
Other 53.79 (3.32) 54.39 (8.37)
Relationship status
Single 52.63 (7.32)
0.61 (2) 0.55
44.17 (14.15)
4.45 (2) 0.01In a relationship 53.97 (7.86) 47.82 (11.61)
Other 55.03 (9.6) 33.15 (13.17)
Work situation
Employed 55.5 (5.89)
6.24 (2) <0.01
49.18 (11.06)
7.47 (2) <0.01Unemployed 49.94 (9.31) 40.92 (11.58)
Other 51.57 (8.24) 40.12 (14.94)
Housing situation
With family 54.05 (7.19)
1.67 (4) 0.16
44.26 (10.89)
2.23 (4) 0.07
With friends/shared flat 55.45 (3.77) 39.37 (17.05)
With partner 54.89 (7.1) 49.64 (10.73)
Alone 51.29 (8.83) 44.01 (13.71)
Other 57.6 59.88
Table 6: Descriptive results of SF-36 global measures and
transition-specific datawith 𝑡-test comparison of mean scores (M
(SD)).
PCS 𝑝 MCS 𝑝
Current
hormone
therapy
Yes 54.03 (6.43) 0.19 46.76 (11.89) 0.04
No 50.94 (11.2) 39.39 (16.04)
Overall gender-
affirming
surgery
Yes 53.83 (6.69) 0.59 46.81 (12.02) 0.01
No 52.67 (10.24) 39.76 (15.33)
the participants underwent surgical GAI, which are gen-
erally only amenable to largely physically healthy patients.
Other studies, however, described no statistically significant
differences in physical functioning compared to the general
population [7, 16, 20].
4.2. Comparison between Transfeminine and Transmasculine
Persons. In line with the findings of Auer et al. [23] and
Table 7: Block-wise multiple regression analysis displaying the
predictive value of transition-specific and sociodemographic factors
on mental quality of life.
Block Predictor MCS
𝛽 𝑝 Corrected 𝑅2 𝑅2 change
1
Transfeminine .373 .005
.144 .158Transmasculine .390 .005
2
Overall gender-
affirming
surgery
.026 .814 .139 .002
3 Hormonaltherapy .029 .786 .135 .003
4 In a partnership
.091 .600 .135 .014
Single .030 .860
5
Employment .299 .003 .196 .071
Unemployment .038 .701
Gorin-Lazard et al. [12, 36], we found no significant dif-
ferences in QoL between transfeminine and transmasculine
persons. However, this contrasts with previous observations
showing physical functioning and general health domains
to be better in transmen than in transwomen and bodily
pain to be better in transwomen than in transmen [7]. The
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latter result coincides with the clinical experience that mas-
culinizing surgical procedures in the genital region are more
complex to perform, are associated with more complications,
and cause more discomfort. The fact that in our sample
much less transmasculine than transfeminine persons have
undergone a genital-confirming operation suggests that some
transmen have decided against carrying out a phalloplasty in
order not to endanger their own QoL. In this sense, the small
number (12 cases) could have contributed to minimizing this
gender-specific difference.
At the same time, there are studies (e.g., Parola et al.
[14]) suggesting that the transmasculine population has better
social functioning and mental health than the transfeminine
population. In literature, this difference is attributed to the
different ways in which society deals with transwomen and
transmen. While transwomen must perform a good, if not
perfect, (cis) passing, society gives transmen more freedom
in this regard [37]. The fact that we have not established
this gender difference cannot be explained with complete
certainty. Nevertheless, it can be assumed that some of the
transient transwomen develop mechanisms over time such
that these stigmatizing situations do not affect their QoL.
4.3. Nonbinary Trans Persons. Our results show considerably
different characteristics within the group of trans partici-
pants. While we did not detect significant differences in the
QoL between transfeminine and transmasculine participants,
persons with a nonbinary gender identity presented the
lowest rates of wellbeing. They showed significantly worse
values in five of eight QoL domains as well as in the men-
tal component summary (MCS) compared to both binary
groups.Moreover, a nonbinary gender identitywas associated
with significantly more depressive symptoms compared to
the transfeminine and transmasculine groups.
The reasons for these clear group differences should
be determined on different levels. First, nonbinary persons
reported specific needs regardingmedicalGAI.Thus, approx-
imately half of this group decided not to seek medical
treatment. This diversity in terms of the GAI undertaken
has been confirmed by other studies [38]. The comparatively
worse QoL of the nonbinary participants could therefore
be related to the lack of a standardized treatment and
accordingly suitable GAI, which cover the specific needs of
this group [39]. Second, the nonbinary group most clearly
questions the binary gender norm that exists in western
societies. As a result, nonbinary individuals are more likely
to be confronted with stigmatization experiences, which can
lead to higher minority stress levels [26] and increased self-
reported disability [28].This in turn has a negative impact on
mental health [28] and especially the emergence of clinically
relevant depressive [2] and anxiety disorders [29], which
ultimately affects QoL.
4.4. Influencing and Predictive Factors. Theone-way ANOVA
and the 𝑡-test comparisons show significant associations
between participants’ mental QoL and certain sociodemo-
graphic factors (age, work situation, and relationship status)
and GAI factors (hormone treatment and surgical measures).
These findings support the investigations of Motmans et al.
[7] who revealed the influence of these sociodemographic
factors on QoL in female and male trans persons. Beyond
that, an association between these sociodemographic factors
and QoL was also outlined among the general population
[40]. With regard to GAI and QoL, the positive relationship
is well documented [11–14].
However, surprisingly, none of these variables had a
relevant predictive impact on the mental QoL in our model.
Only the categories gender andwork situation had significant
regression weights, but these could only explain a small
fraction of the MCS variance. But neither the hormonal nor
the surgical obtained any predictive significance regarding
QoL. This result is, on one hand, in accordance with the
findings of Go´mez-Gil et al. [19] who found employment to
be a (minor) predictive factor of QoL. On the other hand,
this contrasts with previous work by Motmans et al. [7] who
identified not only gender but also age and relationship status
as influencing factors.
The reasons for these disparate observations are complex
and difficult to determine. In principle, they can be related to
definition, methodological, and conceptual issues. Due to the
multiple changes that the trans phenomenon has undergone
over time [1, 41, 42], the inclusion criteria of the respective
trans populations in various studies differ greatly [13, 14, 16,
28]. This is particularly evident in the visibility of nonbinary
trans persons, where the explicit coupling of inclusion and
ICD-10 transsexualism definition criteria leads to automatic
exclusion. In addition, many previous studies have examined
trans persons regardless of their transition stage. Accordingly,
a transparent comparison of the results is impossible due to
these differences in definitions. The absence of a significant
correlation of GAI and QoL in our model might stem from
the biased narrowing of our sample. Given that being in
an initial phase of transition [43] or not yet having begun
planned medical GAI [44] is associated with worse mental
health, the decision to include only trans persons who were
actually able to carry out the interventions they wished could
have led to loosening of the link between mental QoL and
GAI. Furthermore, it might be that the SF-36 questionnaire
does not sufficiently display the QoL concerns of trans
persons. Even if it is a widely used and validated instrument
on QoL [7, 11–14, 20], the SF-36 questionnaire might focus
too much on irrelevant aspects of this population’s wellbeing.
These difficulties raise the conceptual question: which
factors actually impact theQoL of transitioned trans persons?
Our results indicate that the wellbeing of trans individuals
must depend on factors other than GAI. Thus, while medical
interventions are crucial to the transition of trans persons,
they do not define the endpoint of stabilizing QoL [45]. Here,
stigmatization and its resulting gender minority stress [35]
might play an essential role as further influencing factors.
This is in accordance with Bas¸ar et al. [46] who claimed
perceived personal discrimination to predict QoL and Bock-
ting et al. [47] who found social stigma to be positively
associatedwith psychological distress. In this sense, the future
exploration of QoL of trans persons should consider not only
the impact of medical measures but also the psychosocial
consequences of the minority position of trans persons.
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4.5. Limitations and Strengths. Our data cannot be general-
ized to the entire trans population. Due to our study design,
only trans persons who have undergone a medical transition
participated in this study.Thus, the findings cannot be applied
to trans persons who decline the use of GAI. Likewise, trans
persons who have not yet started a medical transition or
are currently in the process of such measure were excluded.
Therefore, our data does not allow any statements regarding
this group of trans persons. At the same time, our inclusion
criteria led to homogenization of the group, whichwas clearly
missing in some previous studies.
A further limitation of our study is the missing informa-
tion on the participants’ current level of gender dysphoria.
This could be an important predictive factor for the QoL of
trans persons. Concurrently, the trans people enrolled here
defined their medical transition as “completed.” In this sense,
we can assume that no trans person who participated hoped
to improve their QoL by initiating further medical measures.
In addition, the cross-sectional design of this study does
not allow further comparison of the QoL before the medical
transition of the participants. Accordingly, no statements can
be made as to whether the GAI changed the QoL of the trans
persons or not. However, this study design allowed for many
trans persons to be made aware of the ongoing investigation.
By using two ways of recruitment and cooperating with trans
organizations, we executed one of the largest surveys of trans
persons in Central Europe.
5. Conclusions
The results emphasize that trans individuals are at greater
risk of decreased QoL and increased mental health problems
than the general population.We provide evidence that gender
nonbinary individuals comprise a particularly vulnerable
group within the trans population and have worse mental
health and, for the first time, we could identify limited QoL
in this group. Therefore, somatic as well as psychosocial QoL
aspects should be addressed in the medical consultation and
education of trans persons. Particularly important are mea-
sures that allow the nonbinary persons to identify themselves
as such and to report on their specific situation.
Finally, our data show that medical GAI are a key
factor in transition and are associated with better mental
wellbeing. Yet, taking into account the fact that we did not
find significant correlations between GAI and QoL in our
sample of transitioned trans people, future research should
seek to adapt the QoL concept to the specific needs of
this population. In particular, the impact of other potential
influencing factors such as stigma should be investigated.
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